prognosis

You have access
PD-1 Expression and its Correlation With Prognosis in Clear Cell Renal Cell Carcinoma
MIN HYE KIM, GYUNG HYUK KO, JEONG HEE LEE, JONG SIL LEE, DONG CHUL KIM, JUNG WOOK YANG, HYO JUNG AN, JI MIN NA and DAE HYUN SONG

In Vivo May 2021, 35 (3) 1549-1553; DOI: https://doi.org/10.21873/invivo.12409
You have access
Implications of Preoperative Transbronchial Lung Biopsy for Non-small Cell Lung Cancer Less than 3-cm
MOTOAKI YASUKAWA, TAKESHI KAWAGUCHI, MICHITAKA KIMURA, TAKASHI TOJO and SHIGEKI TANIGUCHI

In Vivo March 2021, 35 (2) 1027-1031; DOI: https://doi.org/10.21873/invivo.12346
You have access
Neo-Bioscore in Guiding Post-surgical Therapy in Patients With Triple-negative Breast Cancer Who Received Neoadjuvant Chemotherapy
YORIKO HASEGAWA, NOBUAKI MATSUBARA, TAKAHIRO KOGAWA, YOICHI NAITO, KENICHI HARANO, AKO HOSONO, TATSUYA ONISHI, TAKASHI HOJO, MOTOTSUGU SHIMOKAWA and TORU MUKOHARA

In Vivo March 2021, 35 (2) 1041-1049; DOI: https://doi.org/10.21873/invivo.12348
You have access
Sorafenib and Lenvatinib Treatment for Metastasis/Recurrence of Radioactive Iodine-refractory Differentiated Thyroid Carcinoma
YASUHIRO ITO, NAOYOSHI ONODA, TAKUMI KUDO, HIROO MASUOKA, TAKUYA HIGASHIYAMA, MINORU KIHARA, AKIHIRO MIYA and AKIRA MIYAUCHI

In Vivo March 2021, 35 (2) 1057-1064; DOI: https://doi.org/10.21873/invivo.12350
You have access
Prognostic Evaluation of the Site of Invasion in Pathological Stage T3a Renal Cell Carcinoma
GU-SHUN LAI, JIAN-RI LI, SHIAN-SHIANG WANG, CHUAN-SHU CHEN, CHUN-KUANG YANG, SHENG-CHUN HUNG, CHEN-LI CHENG, YEN-CHUAN OU and KUN-YUAN CHIU

In Vivo March 2021, 35 (2) 1083-1089; DOI: https://doi.org/10.21873/invivo.12353
You have access
Palliative Radiotherapy During the Last Month of Life: Have COVID-19 Recommendations Led to Reduced Utilization?
CARSTEN NIEDER, ELLINOR C. HAUKLAND, BARD MANNSAKER and ROSALBA YOBUTA

In Vivo January 2021, 35 (1) 649-652; DOI: https://doi.org/10.21873/invivo.12304
You have access
Beneficial Effects of Intermediate Dosage of Anticoagulation Treatment on the Prognosis of Hospitalized COVID-19 Patients: The ETHRA Study
GARYPHALLIA POULAKOU, EVANGELOS DIMAKAKOS, ANASTASIOS KOLLIAS, KONSTANTINOS G. KYRIAKOULIS, VASILIKI RAPTI, IOANNIS TRONTZAS, CHARALAMPOS THANOS, MAHMOUD ABDELRASOUL, THEODORA VANTANA, KONSTANTINOS LEONTIS, ELENI KAKALOU, KATERINA ARGYRAKI, IOANNIS BARABOUTIS, EVANGELOS MICHELAKIS, EVANGELOS GIAMARELLOS-BOURBOULIS, KATERINA DIMAKOU, GEORGIOS TSOUKALAS, ANGELIKI RAPTI, EVANGELOS D. MICHELAKIS and KONSTANTINOS N. SYRIGOS

In Vivo January 2021, 35 (1) 653-661; DOI: https://doi.org/10.21873/invivo.12305
You have access
Low DUSP4 Expression Is Associated With Aggressive Phenotypes and Poor Prognosis in Gastric Cancer
SEONGSIK BANG, SEUNGYUN JEE, HYUNSUNG KIM, KISEOK JANG, HOSUB PARK, JAE KYUNG MYUNG, DONGHO CHOI, SU-JIN SHIN and SEUNG SAM PAIK

In Vivo January 2021, 35 (1) 131-140; DOI: https://doi.org/10.21873/invivo.12240
You have access
Sulfite Oxidase Is a Novel Prognostic Biomarker of Advanced Gastric Cancer
YUTA YANO, JUN AKIBA, YOSHIKI NAITO, EIJI SADASHIMA, HARUHIKO CHO, TSUNEKAZU HISHIMA and HIROHISA YANO

In Vivo January 2021, 35 (1) 229-237; DOI: https://doi.org/10.21873/invivo.12251
You have access
High MCM6 Expression as a Potential Prognostic Marker in Clear-cell Renal Cell Carcinoma
NU-RI JANG, JINA BAEK, YOUNGHWII KO, PHIL HYUN SONG and MI-JIN GU

In Vivo January 2021, 35 (1) 299-306; DOI: https://doi.org/10.21873/invivo.12259

Main menu

User menu

Search

prognosis

Pages